These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37653730)

  • 1. Expression and prognostic value of AIM1L in esophageal squamous cell carcinoma.
    Zhou L; Gan L; Liu Z
    Medicine (Baltimore); 2023 Aug; 102(34):e34677. PubMed ID: 37653730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma.
    Guo J; Yang Q; Wei S; Shao J; Zhao T; Guo L; Liu J; Chen J; Wang G
    BMC Cancer; 2022 Jul; 22(1):745. PubMed ID: 35799142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic role of FZD6 in esophageal squamous cell carcinoma patients.
    Zhang J; Wang JL; Zhang CY; Ma YF; Zhao R; Wang YY
    Clin Transl Oncol; 2020 Jul; 22(7):1172-1179. PubMed ID: 31748958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
    Zhang Z; Wang J; Han W; Zhao L
    BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of PDGFA predicts poor prognosis of esophageal squamous cell carcinoma.
    Han N; Zhang YY; Zhang ZM; Zhang F; Zeng TY; Zhang YB; Zhao WC
    Medicine (Baltimore); 2021 May; 100(20):e25932. PubMed ID: 34011067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UBE2T Contributes to the Prognosis of Esophageal Squamous Cell Carcinoma.
    Wang X; Liu Y; Leng X; Cao K; Sun W; Zhu J; Ma J
    Pathol Oncol Res; 2021; 27():632531. PubMed ID: 34257599
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W; Liu J; Zhao H
    Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma.
    Wang P; Chen Y; Zheng Y; Fu Y; Ding Z
    Dis Markers; 2021; 2021():5340240. PubMed ID: 34712369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma.
    Li X; Xiao X; Chang R; Zhang C
    J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOC1 predicts a worse prognosis for esophageal squamous cell carcinoma and is associated with tumor immune infiltration during tumorigenesis.
    Cao X; Wu B; Guo S; Zhong W; Zhu S; Zhang Z; Gu L; Li H
    Pathol Oncol Res; 2023; 29():1610976. PubMed ID: 36969562
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification and validation of a prognostic signature of cuproptosis-related genes for esophageal squamous cell carcinoma.
    Zhang Y; Chen K; Wang L; Chen J; Lin Z; Chen Y; Chen J; Lin Y; Xu Y; Peng H
    Aging (Albany NY); 2023 Sep; 15(17):8993-9021. PubMed ID: 37665670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value and functional bioinformatic analysis of spindle- and kinetochore-associated protein 1 in stage IIA esophageal squamous cell carcinoma.
    Hu D; Zhang M; Peng Z
    J Cancer Res Ther; 2020 Sep; 16(5):1157-1164. PubMed ID: 33004764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EXOC3L1: A Novel Prognostic Biomarker Correlated with Immune Infiltration in Esophageal Squamous Cell Carcinoma.
    Zhang ZF
    Med Sci Monit; 2023 Feb; 29():e938512. PubMed ID: 36852560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma.
    Zhang W; Zhou Y; Li C; Xu S; Li M; Liu W; Ma Y; Wang H
    Anal Cell Pathol (Amst); 2020; 2020():2872479. PubMed ID: 33381388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated bioinformatics analysis of differentially expressed genes and immune cell infiltration characteristics in Esophageal Squamous cell carcinoma.
    Feng Z; Qu J; Liu X; Liang J; Li Y; Jiang J; Zhang H; Tian H
    Sci Rep; 2021 Aug; 11(1):16696. PubMed ID: 34404882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of miR-375 as a potential prognostic biomarker for esophageal squamous cell cancer: A bioinformatics analysis based on TCGA and meta-analysis.
    Luo HS; Wu DH
    Pathol Res Pract; 2019 Mar; 215(3):512-518. PubMed ID: 30638952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GINS4 might be a novel prognostic immune-related biomarker of not only esophageal squamous cell carcinoma and other cancers.
    Jin D; Yuan L; Li F; Wang S; Mao Y
    BMC Med Genomics; 2022 Apr; 15(1):75. PubMed ID: 35365175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A more novel and robust gene signature predicts outcome in patients with esophageal squamous cell carcinoma.
    Ma C; Luo H
    Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102033. PubMed ID: 36265781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.